Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Functional Evidence from Deuterated Water Labeling That the Bruton Tyrosine Kinase Inhibitor Ibrutinib Blocks Leukemia Cell Proliferation and Trafficking and Promotes Leukemia Cell Death in Patients with Chronic Lymphocytic Leukemia and small Lymphocytic Lymphoma

Jan A. Burger, MD PhD, Kelvin Li, PhD, Michael Keating, MBBS, Mariela Sivina, PhD, Alessandra Ferrajoli, MD, Annette Jalayer, RN, Xuelin Huang, Hagop M. Kantarjian, MD, William G. Wierda, MD PhD, Susan O'Brien, MD, Marc Hellerstein, MD PhD, Scott Turner, PhD, Claire Emson, PhD, Shih-Shih Chen, PhD, Xiao-Jie Yan, MD PhD, Nicholas Chiorazzi, MD

Blood (2014) 124 (21): 326.

https://doi.org/10.1182/blood.V124.21.326.326

Published: 2014

Journal Articles

Kinetic Measurement of Leukemia-Cell Proliferation Rate By Deuterium Labeling Predicts Time to Initial Treatment of Patients with Chronic Lymphocytic Leukemia

Blood (2014) 124 (21): 829.

https://doi.org/10.1182/blood.V124.21.829.829

Published: 2014

Journal Articles

Correlation of Leukemia-Cell Birth Rate Measured by Heavy Water Labeling with Other Prognostic Markers in Early Stage Chronic Lymphocytic Leukemia.

Elizabeth J Murphy, MD, DPhil, Claire Emson, PhD, Laura Z. Rassenti, PhD, Gregory Hayes, PhD, Daniel Holochwost, Marc Hellerstein, MD, PhD, Nicholas Chiorazzi, MD, Donna Neuberg, ScD, Thomas J. Kipps, MD, PhD, Kanti R Rai, MD

Blood (2009) 114 (22): 60.

https://doi.org/10.1182/blood.V114.22.60.60

Published: 2009

Journal Articles

In Vivo Labeling of Dividing Chronic Lymphocytic Leukemia B Cells Suggests That CXCR4 and CD5 Define the Clonal Subfraction That Recently Proliferatead and Emigrated from a Solid Tissue

Carlo calissano, MD, Rajendra Damle, PhD, Gregory Hayes, PhD, Elisabeth J Murphy, MD, PhD, Marc Hellerstein, MD, PhD, Barbara Sherry, PhD, Matthew S Kaufman, MD, Steven L Allen, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 358.

https://doi.org/10.1182/blood.V112.11.358.358

Published: 2008

Journal Articles

In Vivo Labeling of Newly Synthesized DNA Suggests That the CD38 + Fraction Is Enriched in Proliferating Cells within a Clone of Chronic Lymphocytic Leukemia B Cells.

Carlo Calissano, MD, Rajendra Damle, PhD, Taraneh Banapour, BS, Denise Cesar, Marc Hellerstein, MD, PhD, Steven Allen, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD

Blood (2006) 108 (11): 27.

https://doi.org/10.1182/blood.V108.11.27.27

Published: 2006

NARROW

Functional Evidence from Deuterated Water Labeling That the Bruton Tyrosine Kinase Inhibitor Ibrutinib Blocks Leukemia Cell Proliferation and Trafficking and Promotes Leukemia Cell Death in Patients with Chronic Lymphocytic Leukemia and small Lymphocytic Lymphoma

Kinetic Measurement of Leukemia-Cell Proliferation Rate By Deuterium Labeling Predicts Time to Initial Treatment of Patients with Chronic Lymphocytic Leukemia

Correlation of Leukemia-Cell Birth Rate Measured by Heavy Water Labeling with Other Prognostic Markers in Early Stage Chronic Lymphocytic Leukemia.

In Vivo Labeling of Dividing Chronic Lymphocytic Leukemia B Cells Suggests That CXCR4 and CD5 Define the Clonal Subfraction That Recently Proliferatead and Emigrated from a Solid Tissue

In Vivo Labeling of Newly Synthesized DNA Suggests That the CD38 + Fraction Is Enriched in Proliferating Cells within a Clone of Chronic Lymphocytic Leukemia B Cells.

Email alerts

ASH Publications

American Society of Hematology

Functional Evidence from Deuterated Water Labeling That the Bruton Tyrosine Kinase Inhibitor Ibrutinib Blocks Leukemia Cell Proliferation and Trafficking and Promotes Leukemia Cell Death in Patients with Chronic Lymphocytic Leukemia and small Lymphocytic Lymphoma

Kinetic Measurement of Leukemia-Cell Proliferation Rate By Deuterium Labeling Predicts Time to Initial Treatment of Patients with Chronic Lymphocytic Leukemia

Correlation of Leukemia-Cell Birth Rate Measured by Heavy Water Labeling with Other Prognostic Markers in Early Stage Chronic Lymphocytic Leukemia.

In Vivo Labeling of Dividing Chronic Lymphocytic Leukemia B Cells Suggests That CXCR4 and CD5 Define the Clonal Subfraction That Recently Proliferatead and Emigrated from a Solid Tissue

In Vivo Labeling of Newly Synthesized DNA Suggests That the CD38 + Fraction Is Enriched in Proliferating Cells within a Clone of Chronic Lymphocytic Leukemia B Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only